3.2. Analysis.
Comparison 3: Abaloparatide versus placebo for patients with osteoporosis and CKD stages 3‐4, Outcome 2: Mean change in femoral neck BMD (DXA)
Comparison 3: Abaloparatide versus placebo for patients with osteoporosis and CKD stages 3‐4, Outcome 2: Mean change in femoral neck BMD (DXA)